The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial

Publication Date

2022

Content Type

Article

PubMed ID:

36044317

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS